Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock

Shock

Volumn 7, Issue 2, 1997, Pages 111-118

  Meng, Xianzhong ^a,b   Ao, Lihua ^a   Brown, James M ^a   Fullerton, Dave A ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DEXAMETHASONE; DRUG DERIVATIVE; ENZYME INHIBITOR; N(G) MONOMETHYLARGININE ACETATE; N(G)-MONOMETHYLARGININE ACETATE; NITRIC OXIDE SYNTHASE; S METHYLISOTHIOPSEUDOURONIUM; S-METHYLISOTHIOPSEUDOURONIUM; THIOUREA DERIVATIVE;

ANIMAL; ARTICLE; BLOOD PRESSURE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENDOTOXEMIA; ENZYMOLOGY; HEART CONTRACTION; METABOLISM; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ARGININE; BLOOD PRESSURE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENZYME INHIBITORS; ISOTHIURONIUM; MYOCARDIAL CONTRACTION; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031066709     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199702000-00007     Document Type: Article

References (44)

1. Adams HR, Baxter CR, Parker JL: Reduction of intrinsic contractile reserves of the left ventricle by Escherichia coli endotoxin shock in guinea-pigs. J Mol Cell Cardiol 17:575-585, 1985.
2. McDonough KH, Brumfield BA, Lang CH: In vitro myocardial performance after lethal and nonlethal doses of endotoxin. Am J Physiol 250: H240-H246, 1986.
3. Hung J, Lew WYW: Temporal sequence of endotoxin-induced systolic and diastolic myocardial depression in rabbits. Am J Physiol 265:H810-H819, 1993.
4. Sufferdini AF, Fromm RE, Parker M, Brenner M, Kovacs JA, Wesley RA, Parrillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engt J Med 321:280-287, 1989.
5. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL: Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96:1042-1052, 1995.
6. Schultz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD: The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor-α. Br J Pharmacol 114:27-34, 1995.
7. Murray DR, Freeman GL: Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 78:154-160, 1996.
8. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105:575-580, 1992.
9. Luss H, Watkins SC, Freeswick PD, et al: Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol 27: 2015-2029, 1995.
10. Knowles RG, Moncada S: Nitric oxide synthase in mammals. Biochem J 298:249-258, 1994.
11. Nussler AK, Billiar TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54:171-178, 1993.
12. Ungureanu-Longrois D, Balligand J-L, Kelly RA, Smith TW: Myocardial contractile dysfunction in the systemic inflammatory response syndrome: Role of a cytokine-inducible nitric oxide synthase in cardiac myocyte. J Mol Cell Cardiol 27:155-167, 1995.
13. Kelly RA, Balligand J-L, Smith TW: Nitric oxide and cardiac function. Circ Res 79:363-380, 1996.
14. Brady AJB, Poole-Wilson PA: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263: H1963-H1966, 1992.
15. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176-H182, 1993.
16. Balligand JL, Ungureanu D, Kelly RA, et al: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91:2314-2319, 1993.
17. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M: Endotoxin and cytokines induces direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 28:1631-1639, 1996.
18. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hauler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389, 1992.
19. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
20. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP: A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies. SHOCK 5:116-121, 1996.
21. Thiemermann C, Vane J: Inhibition of nitric oxide synthase reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-591, 1990.
22. Paya D, Gray GA, Stoclet JC: Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats. J Cardiovasc Pharmacol 21:962-930, 1993.
23. Keaney JF Jr, Puyana JC, Francis S, Loscalzo JF, Stamler JS, Loscalzo J: Methylene blue reverses endotoxin-induced hypotension. Circ Res 74: 1121-1125, 1994.
24. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
25. Decking UM, Flesche CW, Godeche A, Schrader J: Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 268:H2640-H2465, 1995.
26. Keller RS, Jones JJ, Kim KF, Myers PR, Adams HR, Parker JL, Rubin L: Endotoxin-induced myocardial dysfunction: Is there a role for nitric oxide? SHOCK 4:338 -344, 1995.
27. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ: The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism of transforming growth factor β. J Clin Invest 95:677-685, 1995.
28. Radomski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Nail Acad Sci USA 87:10043-10047, 1990.
29. Meng X, Brown JM, Ao L, Nordeen SK, Franklin W, Harken AH, Banerjee A: Endotoxin induces cardiac heat shock protein 70 and resistance to endotoxemic myocardial dysfunction. Am J Physiol 271:C1316-C1324, 1996.
30. Lefer A, Rovetto M: Influence of a myocardial depressant factor on physiologic properties of cardiac muscle. Proc Soc Exp Biol 134:269-273, 1970.
31. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS: Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 90:389-398, 1992.
32. Gross SS, Jaffe EA, Levi R, Kilbourn RG: Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 178:823-829, 1991.
33. Gross SS, Levi R: Tetrahydrobiopterin synthesis: An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267:25722-25729, 1992.
34. Geller DA, Nussler AK, Silvio MD, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, Billiar TR: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Nail Acad Sci USA 90:522-526, 1993.
35. Liu S, Adcock IM, Old RW, Barnes PJ, Evans TW: Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 196:1208-1213, 1993.
36. Klabunde RE, Coston AF: Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxin shock. SHOCK 3:73-78, 1995.
37. Zuckerman SH, Shellhaas J, Butler LD: Differential regulation of lipopo-lysaccharide-induced interleukin-1 and tumor necrosis factor synthesis; effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19:301-305, 1989.
38. Southan GJ, Szabo C, Thiemermann C: Isothioureas: Potent inhibitors of nitric oxide synthase with variable isoform selectivity. Br J Pharmacol 114:510-516, 1995.
39. Parker JL, Adams HR: Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxin. Circ Res 72:539-551, 1993.
40. Fullerton DA, McIntyre RC Jr, Hahn AR, Agrafojo J, Koike K, Meng X, Banerjee A, Harken AH: Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am J Physiol 268:L1029-L1035, 1995.
41. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parillo JE: The coronary circulation in human septic shock. Circulation 73:637-644, 1986.
42. Papadakis EJ, Abel FL: Left ventricular performance in canine endotoxin shock. Circ Shock 24:123-131, 1988.
43. Groeneveld AB, van Lambalgen AA, van den Bos GC, Bronsveld W, Nauta JJ, Thijs LG: Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res 25:80-88, 1991.
44. Shepherd RE, McDonough KH, Burns AH: Mechanism of cardiac dysfunction in hearts from endotoxin-treated rats. Circ Shock 19:371-384, 1986.